Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Q3 2024 update: nanomedicine related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that nanomedicine accounted for six pharmaceutical deals announced in Q3 2024,...
Data Insights
Nanomedicine: the leading companies in mRNA delivery lipid nanoparticles revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...